Order from us for quality, customized work in due time of your choice.
Introduction
Depression is one of the common issues affecting pregnant women. Statistics show that 14% to 23% of females might suffer from this health problem during the perinatal period (Yonkers et al., 2009). For this reason, it is vital to address the disease, as if left untreated, it might have numerous adverse impacts on a woman and a child. For this reason, there is a guideline for using antidepressants to treat the condition.
Discussion
Antidepressant use by pregnant women is well studied; however, there is a lack of evidence about outcomes and impact on the fetus (Yonkers et al., 2009). Thus, selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed class of antidepressants for pregnant women (Yonkers et al., 2009). Currently, there is no information supporting specific morphological teratogenic risks (Yonkers et al., 2009). However, it is vital to follow specific guidelines when prescribing antidepressants. First of all, behavioral treatments are recommended for mood disorders. Moreover, the guideline offers algorithms for managing depressed pregnant women who take antidepressants. Following this document, it is possible to prescribe a medication with the minimum impact on women and the fetuss health. At the same time, research shows little consensus on identifying and managing depression in complex cases (Falek et al., 2022). Specific limitations and exclusion criteria are used to determine the list of possible antidepressants (Falek et al., 2022).
Conclusion
This information is vital for making prescriptions in this group during practice. First, behavioral treatments, such as cognitive behavioral therapy, should be considered the first choice. It does not pose any risks for a pregnant woman and a child. In cases when antidepressants are necessary, it is vital to follow the algorithm offered by the official guidelines and ensure the most effective and safe drug is selected.
References
Falek, I., Acri, M., Dominguez, J., Havens, J., McCord, M., Sisco, S., Wilcox, W., & Hoagwood, K. (2022). Management of depression during the perinatal period: state of the evidence. International Journal of Mental Health Systems, 16(21). Web.
Yonkers, K. A., Wisner, K. L., Stewart, D. E., Oberlander, T. F., Dell, D. L., Stotland, N., Ramin, S., Chaudron, L., & Lockwood, C. (2009). The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstetrics and Gynecology, 114(3), 703713. Web.
Order from us for quality, customized work in due time of your choice.